ENZN has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
ENZN has been removed from your Stock Email Alerts list.
|
Ticker![]() | Date
|
Action |
Impact
![]() |
Price Range (Average)*
![]() |
Current Price | Change from Average![]() |
Comment | Current Shares | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ENZN | 2011-09-30 | Add | 0.07% | $7.24 - $10.37 ($8.8) | $ 3.07 | -65% | Add 25% | 5,904,863 | ||
| ENZN | 2010-12-31 | Add | 0.41% | $10.5 - $12.5 ($11.36) | $ 3.07 | -73% | Add 67.7% | 4,723,891 | ||
| ENZN | 2009-03-31 | Add | 0.09% | $5.27 - $7.1 ($6.1) | $ 3.07 | -50% | Add 14.61% | 2,816,861 | ||
| ENZN | 2008-03-31 | Add | 0.14% | $8.16 - $9.25 ($8.7) | $ 3.07 | -65% | Add 39.64% | 2,457,683 | ||
| ENZN | 2007-06-30 | Buy | 0.32% | $7.92 - $8.81 ($8.4) | $ 3.07 | -64% | New holding, 1740001 sh. | 1,740,001 | ||
| | ||||||||||
| Ticker | Guru Name | Portfolio Date* | Current Shares | % of Shares Outstanding | % of Total Assets Managed | Change from Last Holdings | Holding History |
|---|---|---|---|---|---|---|---|
| ENZN | Charles Brandes | 2013-03-31 | 360,865 | 0.83 | 0.02 | +432.17% | |
| ENZN | Michael Price | 2013-03-31 | 748,800 | 1.71 | 0.37 | ||
| ENZN | Carl Icahn | 2013-03-31 | 5,904,863 | 13.51 | 0.13 | ||
| ENZN | Seth Klarman | 2013-03-31 | 7,691,453 | 17.6 | 0.94 | -2.02% |
Most recent portfolio changes are included for Premium Members only!ENZN: Insider Buys/Sells Click Here for All Insider Trades. |
| Insider | Position | Date | Trades | Shares | Trade Price ($) | Change (%) | Details |
|---|---|---|---|---|---|---|---|
| LEBUHN ROBERT | Director | 2012-08-14 | Sell | 5,820 | $6.58 | -53.34 | view |
| LEBUHN ROBERT | Director | 2012-08-10 | Sell | 1,933 | $6.58 | -53.34 | view |
| HEBARD GEORGE | Interim PEO and Interim COO | 2012-06-20 | Buy | 5,000 | $6.88 | -55.38 | view |
| Rackear Andrew D. | VP and General Counsel | 2012-06-05 | Sell | 1,614 | $6.81 | -54.92 | view |
| Conover Charles | SVP, R&D Program Management | 2012-06-05 | Sell | 25,000 | $6.78 | -54.72 | view |
| Young Richard A | Director | 2012-03-15 | Sell | 2,000 | $6.92 | -55.64 | view |
| Rackear Andrew D. | VP and General Counsel | 2011-11-10 | Sell | 3,766 | $6.68 | -54.04 | view |
| Buchbinder Aby | VP, Clinical Development | 2011-11-08 | Sell | 2,700 | $7.06 | -56.52 | view |
| LEBUHN ROBERT | Director | 2011-06-01 | Sell | 8,702 | $10.57 | -70.96 | view |
| Ogden Mark L | Acting VP of Fin & Prin FO | 2011-02-28 | Buy | 2,000 | $10.65 | -71.17 | view |
Add Notes, Comments or Ask Questions
Comments